BenzingaOctober 5, 2026 at 6:09 AM NY22 Days Ago
TD Cowen Maintains Buy on CME Group, Raises Price Target to $300
TD Cowen analyst Bill Katz maintains CME Group (NASDAQ:CME) with a Buy and raises the price target from $292 to $300.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
